Eaton Vance Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $31.1M | Buy |
126,759
+143
| +0.1% | +$35.1K | 0.05% | 354 |
|
|
2022
Q2 | $31.3M | Sell |
126,616
-925
| -0.7% | -$229K | 0.04% | 363 |
|
|
2022
Q1 | $42.2M | Buy |
127,541
+9,741
| +8% | +$3.23M | 0.05% | 344 |
|
|
2021
Q4 | $42.3M | Buy |
117,800
+28
| +0% | +$10.1K | 0.05% | 329 |
|
|
2021
Q3 | $38.1M | Buy |
117,772
+8,189
| +7% | +$2.65M | 0.05% | 317 |
|
|
2021
Q2 | $34.2M | Buy |
109,583
+568
| +0.5% | +$177K | 0.05% | 349 |
|
|
2021
Q1 | $34.7M | Buy |
109,015
+12,927
| +13% | +$4.12M | 0.05% | 332 |
|
|
2020
Q4 | $31.2M | Sell |
96,088
-24,379
| -20% | -$7.9M | 0.05% | 339 |
|
|
2020
Q3 | $33.4M | Buy |
120,467
+7,986
| +7% | +$2.21M | 0.06% | 274 |
|
|
2020
Q2 | $27.2M | Buy |
112,481
+21
| +0% | +$5.07K | 0.06% | 290 |
|
|
2020
Q1 | $16.3M | Buy |
112,460
+23,795
| +27% | +$3.45M | 0.04% | 324 |
|
|
2019
Q4 | $15.1M | Buy |
88,665
+13
| +0% | +$2.22K | 0.03% | 379 |
|
|
2019
Q3 | $15.8M | Buy |
88,652
+7,652
| +9% | +$1.36M | 0.03% | 353 |
|
|
2019
Q2 | $21.1M | Buy |
81,000
+76
| +0.1% | +$19.8K | 0.05% | 299 |
|
|
2019
Q1 | $23.1M | Buy |
80,924
+2,244
| +3% | +$641K | 0.05% | 271 |
|
|
2018
Q4 | $25.6M | Buy |
78,680
+18,750
| +31% | +$6.09M | 0.07% | 242 |
|
|
2018
Q3 | $27M | Hold |
59,930
| – | – | 0.06% | 250 |
|
|
2018
Q2 | $24.5M | Sell |
59,930
-46,248
| -44% | -$18.9M | 0.06% | 256 |
|
|
2018
Q1 | $30.9M | Buy |
106,178
+56,545
| +114% | +$16.5M | 0.04% | 312 |
|
|
2017
Q4 | $9.3M | Buy |
49,633
+5,262
| +12% | +$986K | 0.02% | 399 |
|
|
2017
Q3 | $7.48M | Buy |
44,371
+22,235
| +100% | +$3.75M | 0.02% | 419 |
|
|
2017
Q2 | $3.17M | Buy |
22,136
+13,746
| +164% | +$1.97M | 0.01% | 574 |
|
|
2017
Q1 | $1.05M | Hold |
8,390
| – | – | ﹤0.01% | 767 |
|
|
2016
Q4 | $945K | Buy |
+8,390
| New | +$945K | ﹤0.01% | 738 |
|